10
Participants
Start Date
February 15, 2019
Primary Completion Date
June 3, 2021
Study Completion Date
June 30, 2021
Airvo2
Treatment with HighFlow through the Airvo2 device, 8 hours per day
Usual care
"High flow treatment is investigated as an add on treatment to the personalized care already prescribed to the patients. As patients with interstitial lung disease very often demand very different treatment set ups treatment will vary in the individual patients. All will, however, be treated with ambulatory oxygen. Usual care will be unaltered a month before inclusion in the study in each of the individual patients"
Aalborg University Hospital, Aalborg
Fisher and Paykel Healthcare
INDUSTRY
Aalborg University Hospital
OTHER